Product Information
BRIMONIDINE TARTRATE 0.1% DROP is a generic product labeled by Pacific Pharma, Inc., priced at $10.1674 per ML under NDC 82182032105. Its NADAC has been published 133 times since Feb 7, 2024.
FDA first approved this application on Aug 19, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/mL
Manufacturer
Pacific Pharma, Inc.NDC
82182032105
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021770FDA Approved
8/19/2005
TE Code
AB
On Market Since
1/2/2024
Pharmacological Classes
Price Statistics
The NADAC for BRIMONIDINE TARTRATE 0.1% DROP has been published 133 times since Feb 7, 2024, and over the history we have for it it has declined 68.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1674 per ML |
|---|---|
| All-time high | $31.9324 (Feb 14, 2024) |
| All-time low | $9.9870 (Jun 17, 2026) |
| 52-week high | $15.3158 |
| 52-week low | $9.9870 |
| Median price | $15.3659 |
| Average price | $16.3747 |
| Largest weekly change | -35.2% (Apr 17, 2024) |
| Weeks tracked | 133 |
| Tracking since | Feb 7, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRIMONIDINE TARTRATE 0.1% DROP?
The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE TARTRATE 0.1% DROP, manufactured by Pacific Pharma, Inc., is $10.1674 per ML (NDC 82182032105), effective Aug 19, 2026.
How has the price of BRIMONIDINE TARTRATE 0.1% DROP changed over time?
Over the history we have for it, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has declined 68.2%. It has been tracked across 133 weekly CMS publications since Feb 7, 2024.
What are the highest and lowest recorded NADAC prices for BRIMONIDINE TARTRATE 0.1% DROP?
Since Feb 7, 2024, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has ranged from a low of $9.9870 (Jun 17, 2026) to a high of $31.9324 (Feb 14, 2024), with a median of $15.3659 per ML.
Are there cheaper alternatives to BRIMONIDINE TARTRATE 0.1% DROP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE TARTRATE 0.1% DROP, is $6.7507 per ML — about 34% below BRIMONIDINE TARTRATE 0.1% DROP.
Who manufactures BRIMONIDINE TARTRATE 0.1% DROP?
BRIMONIDINE TARTRATE 0.1% DROP (NDC 82182032105) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.